secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-08-01T23:59:59+00:00
Accession:  0001193125-22-207645
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD raises $15M from Rubric, extends debt maturity to Sept 2022
--------------------------------------------------------------------------

- Issued 15,000 Series A Preferred ($1,000 stated value) and 565,000 common shares to Rubric for $15M gross proceeds.
- Rubric owns ~18.3% of common stock post-closing; Series A has $1,333/share liquidation preference and matures Dec 31, 2022.
- Financing Agreement with Sixth Street extended to Sept 30, 2022; can extend to Nov 30 if $7M additional equity raised.
- Sixth Street received warrants to buy up to 200,000 common shares at $0.01, plus 125,000 per monthly extension.
- Proceeds used for working capital and general corporate purposes; Board evaluating strategic alternatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312522207645/0001193125-22-207645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312522207645/d356180d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-207645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer